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Abstract
Problem 1 of the Genetic Analysis Workshop 13(GAW13) contains longitudinal data of
cardiovascular measurements from 330 pedigrees. The longitudinal data complicates the phenotype
definition because multiple measurements are taken on each individual. To address this
complication, we propose an approach that uses generalized estimating equations to obtain
residuals for each time point for each person. The mean residual is then taken as the new
phenotype with which to use in a variance components linkage analysis. We compare our
phenotype definition approach to an approach that first reduces the multiple measurements to a
single measurement and then models these summary statistics as regression terms in a variance
components analysis. For each approach, multipoint linkage analysis was performed using the
residuals and the SOLAR computer program. Our results show little difference between the
methods based on the LOD scores.
Background
The phenotype definition is an important component of
gene mapping. In gene mapping studies, each individual
is assigned a phenotypic value for a particular trait of
interest. This phenotype is then tested for cosegregation
with certain markers. If a susceptibility locus exists, then
individuals with similar trait values should have higher-
than-expected allele sharing at this locus.
The data from the Framingham Heart Study complicates
the phenotype definition in that up to 21 measurements
over a 40-year time span were taken from each person
(Cohort 1) or five measurements taken over a 20-year
time span (Cohort 2). Moreover, these multiple measure-
ments from a person are correlated with each other. Thus,
it is unclear as how to define a phenotype given the corre-
lated repeated measures. One approach would be to
model each time point in a regression analysis and then
combine the parameter estimates [1]. Another approach
would be to model all the time points in a regression anal-
ysis, i.e., a multivariate response outcome [2]. This
approach might be difficult to apply to the Framingham
data because the number of time points in Cohort 1 (21
measurements) result in a large number of parameters to
estimate. A third approach would be to reduce the multi-
ple measurements from each person to a single measure-
ment, thus eliminating the problem of correlated
measurements within a subject. This is the approach taken
by Levy et al. [3]. In their analysis, they first found the
average systolic blood pressure (SBP), average age, and
average body mass index (BMI) for each person. They
then regressed the average SBP on the average age and
average BMI. The residuals from this linear regression
analysis were used as the phenotype in a quantitative
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linkage analysis. We applied an alternative summary-sta-
tistic approach. First, we modeled SBP on the covariates
using a longitudinal analysis method and then averaged
the residuals across the multiple measurements for each
person. The average residual was then the individual's
phenotype that was used in the linkage analysis.
We hypothesize that our approach will provide more link-
age information because all of the data, rather than sum-
mary statistics, are used to estimate the parameters in the
regression model. The approach of Levy et al. does use all
of the data, but by averaging the variables first, informa-
tion about variability is lost. We test this hypothesis by
comparing the genome-wide linkage results using our
phenotype-definition approach with the genome-wide
linkage results using the phenotype-definition approach
of Levy et al.
Methods
Data
Problem I data consists of 2885 individuals from 330 ped-
igrees. Of the 2885 individuals, 1213 were from Cohort 1.
Cohort 1 individuals were followed every 2 years for a
total of 21 measurements. Cohort 2 individuals are off-
spring of Cohort 1 individuals, and they were followed
every 4 years for a total of five measurements. At each fol-
low-up, extensive amount of medical information was
obtained, including SBP, age, height, weight, and high-
blood pressure treatment information.
Longitudinal analysis
We are interested in finding the genes that increase the risk
for cardiovascular (CV) disease. We used SBP as a surro-
gate to CV. We first analyzed the longitudinal data follow-
ing the methods of Levy et al., denoted as Method 1.
Specifically, we calculated the mean SBP,  , for the ith
individual. We then used linear regression to regress   on
(  -  ) and (  -  ), where   is the mean age of
an individual,   is the mean BMI of an individual,   is
the sample mean age, and   is the sample mean BMI.
The residuals from this regression analysis are then used
as the quantitative phenotype for the linkage analysis.
We also analyzed the longitudinal data with an alternative
approach (Method 2). We first found the residuals for
each time point. We then calculate the average residual
over all time points for each person to use as the pheno-
type in the linkage analysis. To calculate the residuals, we
used generalized estimating equations (GEE) [4]. This is a
linear models approach that accounts for the dependency
among the time points. We used an exchangeable working
correlation matrix in the analysis and regressed SBP on
age and BMI at the ith time point. Residuals were then
obtained for each time point.
For both approaches, we analyzed the phenotype data
from males and females and from Cohorts 1 and 2 data
separately, resulting in four longitudinal analyses. This
was done to allow for different rates of change for age and
BMI for each of the male/female and Cohort 1/Cohort 2
combinations. The residuals obtained from each of these
four analyses were combined into one set of residuals,
which was then used in the linkage analysis. The correla-
tion between the two phenotypes used in the linkage anal-
ysis is 0.97.
Linkage analysis
Multipoint linkage analysis of the residuals were com-
pleted using a variance-component approach, which tests
for linkage by testing whether the variance component
associated with a particular chromosomal location is sig-
nificantly greater than zero. The analyses were performed
using SOLAR [5]. Since we adjusted for age and BMI in the
longitudinal analysis and ran separate longitudinal analy-
ses for each sex and cohort combination, these effects
were not modeled in the linkage analysis.
Results
Results of the linkage analyses from the two different
approaches are presented in Figure 1. Multipoint LOD
scores are plotted against chromosomal location for all 22
autosomes. From this figure, we see that the two analytical
methods had similar results. This finding is also sup-
ported by the high correlation ( ) between the
two phenotypes. Moreover, neither of these methods
reported LOD scores above 3. The largest multipoint LOD
score that was observed was on chromosome 5, with a
LOD score of 2.35 (Method 1) and a LOD score of 1.73
(Method 2) at 32 cM. These results were close to the result
found by Levy et al.; they reported a multipoint LOD score
of 1.9 at 23 cM.
Levy et al. found significant evidence for linkage (LOD
score = 4.7) at 67 cM on chromosome 17. Although we
did not achieve that level of significance with either
approach (LOD score of 1.96 and 1.43 at 68 cM for Meth-
ods 1 and 2, respectively), we do see a peak at that
location.
Discussion
We present an alternative approach to deriving a pheno-
type from longitudinal data based on the GEE methodol-
ogy, which accounts for the repeated measures from each
observation. We hypothesize that our approach would
provide more linkage information than that of Levy et al.
because our approach uses all of the data to estimate the
parameter estimates in the regression model. The
yi
yi
xi1 x1 xi2 x2 xi1
xi2 x1
x2
ˆ . ρ= 09 7BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S13
Page 3 of 4
(page number not for citation purposes)
Results from a genome-wide scan of standardized residuals of SBP Figure 1
Results from a genome-wide scan of standardized residuals of SBP. Dotted lines denotes results from Method 1 phe-
notype analysis; solid line denotes results from Method 2 phenotype analysis.Publish with BioMed Central    and   every 
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approach of Levy et al. averages the longitudinal data first,
thereby reducing the variability of the data, and then
models the summary statistics in a regression analysis.
What we observed, however, was that the approaches pro-
vided essentially the same amount of genetic information
based on how similar the LOD scores are across the
genome and how correlated the two phenotypes were.
The two regions that had LOD scores of about 1.5 or
higher occurred on chromosomes 5 and 17. At both
regions, Method 1 had a LOD score that was about 0.55
units greater than that of Method 2. For the other regions,
the results were similar or inconclusive, such as that found
on chromosome 22. Since the maximum LOD score was
about 1 on chromosome 22, no conclusions can be made
about the difference between the methods in this region.
This is because of the strong potential of false positives
with such a low LOD score. The overall similarity between
the methods indicates that little or no loss of information
occurs by reducing the multiple measurements from each
person to a single measurement before adjusting for other
covariates.
A limitation of our study is that we use the real data to
compare the two statistical methods. A more accurate
comparison should be made with the use of simulated
data, in which the true gene locations are known a priori.
With simulated data, empirical type I error rates and
power can then be determined for both methods, but a
simulation study such as this requires at least 1000 repli-
cates to appropriately test at the 5% significance level; the
simulated data from GAW had only 100 replicates. We
suspect that the conclusions drawn from the use of the
simulated data (with 100 replicates) would not have been
much more accurate than what we observed from the used
of the real data. Another limitation of our study is that our
approach (Method 2) did not account for familial rela-
tionships in the analysis. An assumption of GEE is inde-
pendence among subjects, and a violation of this
assumption may bias parameter estimates. We do observe
a difference in parameter estimates between Cohorts 1
and II. This difference could be due to the fact that Cohort
2 consists of related subject, due to the fact that more data
are available in Cohort 1, or it even could be due to ascer-
tainment differences between the cohorts. However,
based on Figure 1, a violation of this independence
assumption of GEE does not appear to be a problem
because both Method 1 and 2 had essentially the same
LOD scores across the genome.
We note that our results from Method 1 differed from the
published results of Levy et al. Even though our Method 1
was similar to that of Levy et al., our analysis method was
not as extensive as theirs, e.g., Levy et al. accounted for
treatment effects of hypertension, and they had inclusion
criteria specifying which subjects to include in the analy-
sis. In contrast, we included all subjects who had both
phenotype and genotype information. Moreover, the Levy
et al. analysis had two additional pedigrees. Thus, we
expected the two results to differ. However, we emphasize
that the primary goal here was to compare two analytical
approaches rather than replicate the findings of Levy et al.
In summary, since the two approaches provided similar
results, we conclude that Method 1 is the more parsimo-
nious approach to use because it requires fewer assump-
tions in the data analysis.
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